NTAP
64
2
TDC
75
4
HOG
29
-4
AMAT
36
5
VTR
49
-3
MKC
56
8
PBI
60
-5
JPM
63
-4
PDCO
35
-3
VLO
40
-2
VRSN
53
3
HPE
55
11
BAC
50
-3
INTU
51
2
NI
75
2
ORLY
53
-3
DG
2
-6
DE
46
3
SYF
85
2
MCO
73
3
NTAP
64
2
TDC
75
4
HOG
29
-4
AMAT
36
5
VTR
49
-3
MKC
56
8
PBI
60
-5
JPM
63
-4
PDCO
35
-3
VLO
40
-2
VRSN
53
3
HPE
55
11
BAC
50
-3
INTU
51
2
NI
75
2
ORLY
53
-3
DG
2
-6
DE
46
3
SYF
85
2
MCO
73
3
Financhill
Back

Vera Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60

VERA
Vera Therapeutics

Last Price:
47.08
Seasonality Move:
52.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Vera Therapeutics Price Quote

$47.08
+1.33 (+2.91%)
(Updated: November 21, 2024 at 5:55 PM ET)

Vera Therapeutics Key Stats

Buy
60
Vera Therapeutics (VERA) is a Buy
Day range:
$44.97 - $46.46
52-week range:
$12.28 - $51.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
9.82%
Volume:
393.9K
Avg. volume:
941.7K
1-year change:
238.89%
Market cap:
$2.8B
Revenue:
$0
EPS:
$-2.61

How Much Does Vera Therapeutics Make?

Data Unavailable

Is Vera Therapeutics Growing As A Company?

Data Unavailable

Vera Therapeutics Stock Price Performance

What Is Vera Therapeutics 52-Week High & Low?

Vera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vera Therapeutics?

  • How Much Debt Does Vera Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vera Therapeutics Have?
    Cash and short term investments quarterly total is $353.3M
  • What Is Vera Therapeutics’s Book Value Per Share?
    Book value per share is 5.25

Is Vera Therapeutics Cash Flow Positive?

  • What Is VERA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$120.6M
  • What Is Vera Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $305.5M
  • What Is Vera Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$185.1M

Vera Therapeutics Return On Invested Capital

Data Unavailable

Vera Therapeutics Earnings Date & Stock Price

Vera Therapeutics Competitors

  • Who Are Vera Therapeutics's Competitors?
    Below is a list of companies who compete with Vera Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • PROCEPT BioRobotics Corp (PRCT)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Vera Therapeutics Dividend Yield

Vera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -38.73%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 63.91
Upside from Last Price: 39.69%

Major Shareholders

  • How many VERA shares are owned by institutional investors?
    79.8M VERA shares are owned by institutional investors
  • How many VERA shares are owned by insiders?
    615.9K VERA shares are owned by insiders